Sacking Employee for "Poor Decision-Making" While Off Duty Was Harsh

Why It Matters

The decision signals that Australian courts will scrutinize rapid dismissals for off‑duty drug use, compelling employers to adopt fairer, evidence‑based processes. It may reshape how companies enforce drug‑and‑alcohol policies while protecting employee rights.

Key Takeaways

• Dismissal ruled harsh and unreasonable by Fair Work Commission
• Off‑duty cannabis use triggered positive roadside drug test
• Employer acted with undue haste, lacking sufficient evidence
• Case highlights need for proportional disciplinary processes
• Employers must balance safety with fair procedural standards

Pulse Analysis

Australian labour tribunals are increasingly vigilant about the balance between workplace safety and procedural fairness. In the recent Sleepeezee Bedding case, the Fair Work Commission emphasized that even clear policy breaches must be met with a measured response. While the truck driver’s off‑duty cannabis consumption resulted in a positive roadside test, the commission found the employer’s immediate termination lacked the thorough investigation and documentation required under Australian unfair‑dismissal law. This reflects a broader judicial trend that discourages knee‑jerk terminations and demands robust evidentiary standards before depriving an employee of their livelihood.

Employers across sectors are taking note, especially those in safety‑critical roles such as transport, construction, and mining. The ruling serves as a cautionary tale: drug‑and‑alcohol (D&A) policies must be paired with clear, graduated disciplinary frameworks that allow for mitigation, testing verification, and employee representation. Companies are now urged to revisit their D&A protocols, ensuring they include steps like confirmatory testing, written warnings, and opportunities for the employee to present evidence of recent use or medical explanations. By embedding these safeguards, organisations can protect operational integrity while reducing the risk of costly legal challenges.

The broader market implication is a potential shift toward more nuanced drug‑policy enforcement, balancing zero‑tolerance stances with legal defensibility. As remote work and flexible schedules become commonplace, the line between off‑duty conduct and workplace impact blurs, prompting regulators to demand clearer standards. For businesses, the key takeaway is to invest in comprehensive compliance programs that align with both safety imperatives and the evolving jurisprudence on fair dismissal. This approach not only mitigates litigation exposure but also fosters a workplace culture that respects employee rights while maintaining operational safety.